Pathology Clinical Trials 2024

Pathology Clinical Trials 2024

Pathology research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in pathology clinical trials today.

Pathology Clinical Trials

Here are the 6 most popular medical studies for pathology

Popular filter options for pathology trials

Pathology Clinical Trials With No Placebo

View 30 pathology medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to pathology

What are the top hospitals conducting pathology research?

In the realm of pathology, hospitals dedicated to unraveling the mysteries of diseases and improving patient outcomes take center stage. Among them is The University of Alabama at Birmingham in Birmingham, where innovative research is currently underway with two active pathology trials. While they may not have a history of previous studies in this field, their commitment to advancing knowledge and understanding cannot be overlooked. Similarly, UCLA's Jonsson Comprehensive Cancer Center in Los Angeles has also prioritized pathology research with two ongoing clinical trials focused on this crucial area. It is worth noting that these institutions are making significant strides despite not having conducted any past pathology trials.

Another prominent hospital contributing to the field is Henry Ford Health in Royal Oak. Although they currently have one active trial exploring aspects of pathology, their dedication to pushing boundaries warrants recognition. Meanwhile, across the country at UCSF Memory and Aging Center in San Francisco, researchers are actively engaged in one groundbreaking pathology trial aimed at shedding light on complex diseases affecting memory and cognition.

Lastly but by no means least important,Beth Israel Deaconess Medical Center located amidst Boston's vibrant medical community has been tirelessly working towards better understanding through its single active trial dedicated entirely to studying various facets within Pathology domain.Though it lacks historical data for referring back yet it remains undeterred showcasing sheer devotion prevailing among experts committed towards enhancing healthcare standards

These esteemed hospitals display unwavering commitment when it comes to investigating pathological conditions that affect countless individuals worldwide. Their collective efforts underscore the importance of cutting-edge research as we strive towards new breakthroughs essential for improving diagnostic accuracy and treatment strategies for patients everywhere

Which are the best cities for pathology clinical trials?

When it comes to pathology clinical trials, a few cities stand out as leaders in research and development. Chicago, Illinois tops the list with 3 active trials focusing on diverse areas such as body weight walking, hip arthroscopy, and imaging techniques like [18F]NAV4694. Royal Oak, Michigan follows closely behind with 2 ongoing studies exploring treatment options and surgical interventions like PAO with hip arthroscopy. Lastly, Birmingham in Alabama offers 2 active trials investigating innovative PET scans like [11C]PiB and 18F-labeled DPA-714. These cities provide individuals interested in pathology clinical trials access to cutting-edge research that pushes the boundaries of diagnostic methods and treatments.

Which are the top treatments for pathology being explored in clinical trials?

In the realm of clinical trials, several top treatments are currently being explored for pathology. These include:

  • Daratumumab: Engaged in six active trials and 134 all-time breast cancer trials since its introduction in 2012.
  • Belantamab mafodotin: Under scrutiny with four ongoing trials and a total of 26 breast cancer trials to date, starting from 2018.
  • Lenalidomide: Being investigated in three active breast cancer studies alongside an impressive history of 280 clinical trials since its inception in 2003.

These innovative treatments offer hope for advancing the field of pathology and improving outcomes for patients worldwide.

What are the most recent clinical trials for pathology?

Exciting advancements are being made in the field of pathology, as recent clinical trials offer new possibilities for diagnosis and treatment. One such trial explores a virtual group speech therapy intervention program, guided by a patient partner. By leveraging technology, patients can benefit from personalized therapy sessions that address their specific needs. Additionally, verdiperstat shows promise as a potential treatment option for pathology patients. This compound is currently undergoing Phase 1 testing to evaluate its safety and efficacy. The research also includes studies focused on Down syndrome-related pathology and the use of C-11 ER176 PET/CT imaging to aid in diagnosis. These groundbreaking trials signify significant progress in understanding and managing various pathologies, bringing hope to both patients and medical professionals alike.

What pathology clinical trials were recently completed?

Several recent clinical trials in the field of pathology have successfully concluded, signifying significant advancements in diagnosing and understanding diseases. Notably, a trial focusing on Uproleselan sponsored by Washington University School of Medicine was completed in October 2021. Additionally, the National Cancer Institute wrapped up a trial investigating mRNA-1273 therapy in September 2021. Another noteworthy completion occurred with AgenTus Therapeutics' agenT-797 study back in January 2021. These trials highlight the dedication and progress made by researchers seeking to improve pathological diagnosis and treatment options for patients.